HT9406-26-Q-E028
PAP Smear Sample PREP System
DEPT OF DEFENSE > DEFENSE HEALTH AGENCY (DHA) > DEFENSE HEALTH AGENCY
Quick analysis
DHA RFQ for a PAP Smear Monolayer Sample PREP System (medical lab equipment) under NAICS 339112 and PSC 6515; this is outside Trace’s core SATCOM/C5ISR/CDS/IT lanes.
SF1449 header explicitly references Women-Owned Small Business (WOSB), indicating a likely WOSB set-aside; Trace is not WOSB-eligible (per company profile).
No detailed technical specs, quantities, or confirmed set-aside language were visible in the extraction, limiting certainty; however, evidence strongly suggests a medical device commodity buy.
Place of performance shows Germany in the metadata, adding OCONUS delivery/logistics complexity for an item we do not manufacture or resell.」「Low strategic value for Trace; NAICS 339112 is listed as a registered but lower BD priority in the company profile, and there is no relevant past performance with DHA medical devices.
Scope summary
- Provide a PAP Smear Monolayer Sample PREP System as a commercial product (SF1449).
- Comply with FAR commercial clauses (52.212-1/3/4/5).
- Potential WOSB set-aside per SF1449 header.
- Delivery likely OCONUS (metadata indicates Germany).
Dimension scores
The requirement is for a medical laboratory sample-prep system (NAICS 339112; PSC 6515). Trace’s core capabilities are SATCOM/LEO, CDS/NSA TI, C5ISR/JADC2, tactical edge compute, OCC, SE&I, IT O&M (company_profile). No evidence of medical device supply/manufacturing capability.
Company profile lists DISA, USAF, USSF, MDA, Army programs; no DHA medical device or lab equipment past performance. Mission area and product type are not aligned with Trace’s recorded past performance.
This appears to be a stand-alone commercial RFQ (SF1449) on SAM.gov, not restricted to a vehicle. Trace can theoretically access a full-and-open RFQ; however, potential WOSB set-aside would limit access as a prime.
Commodity medical device buy where OEMs/authorized medical distributors have advantage. Header indicates WOSB emphasis; Trace is not WOSB. No differentiators in this lane per company profile.
High pursuit risk: likely WOSB set-aside (eligibility risk), outside core capability (supply chain risk), and OCONUS delivery to Germany per metadata. Technical/mission execution risk is low for true OEMs/distributors, but high for Trace due to mismatch.
NAICS 339112 is registered but designated lower BD priority (company_profile). This buy does not expand core lanes, target vehicles, or strategic agencies/missions for Trace.
SF1449 header explicitly states “WOMEN-OWNED SMALL BUSINESS (WOSB).” Trace is not WOSB (company_profile). While set-aside cannot be 100% confirmed from extraction alone, evidence indicates likely ineligibility as a prime.
Concerns
- Potential WOSB set-aside makes Trace ineligible as a prime.
- Outside Trace’s core and product portfolio; lack of OEM/distributor status for medical equipment.
- OCONUS delivery/logistics to Germany for medical device.
- Short RFQ response window (~9 days from posting).
Teaming opportunities
- Would require a WOSB prime contractor to access as a prime/sub if set-aside is confirmed.
- Need an OEM or authorized medical equipment distributor with relevant catalog and certifications.
- OCONUS shipping/logistics partner capable of delivering to Germany for medical devices.
Competitive position
- No win themes recorded.
Bid/No bid factors
- SF1449 header indicates WOSB focus; Trace is not WOSB.
- NAICS 339112 (medical devices) is a lower BD priority for Trace.
- Product-centric medical lab requirement unrelated to Trace’s core capabilities.
- Place of performance in Germany (metadata) adds complexity for non-specialists.
- Lack of visible technical specs and set-aside confirmation in extraction limits certainty but trend is unfavorable.
Documents
Download all
Solicitation HT940626QE028 PAP Smear Monolayer Sample PREP System.pdf
Download
Defense Health Agency solicitation (SF1449-style) titled for a PAP Smear Monolayer Sample PREP System (filename HT940626QE028). The 35-page PDF is issued by DHA HCD Southeast (Frederick, MD) and includes standard commercial-solicitation FAR references and a named point of contact (Hyun Townsley). The cover/header explicitly references Women-Owned Small Business (WOSB) and lists solicitation metadata (form fields) but the extraction does not include detailed technical requirements or performance/location specifics.
- Document is a DHA solicitation (SF1449 commercial solicitation form) — issuer: DEFENSE HEALTH AGENCY, HCD SOUTHEAST, 808 Schreider Street, Frederick, MD 21702
- Filename/identifier: HT940626QE028; title indicates PAP Smear Monolayer Sample PREP System (solicitation for medical lab/sample-prep equipment)
- Document length: 35 pages (full solicitation package present in PDF)
- Header explicitly shows 'WOMEN-OWNED SMALL BUSINESS (WOSB)' — suggests WOSB focus or solicitation template referencing small-business categories
- FAR clauses referenced on form (52.212-1, 52.212-3, 52.212-4, 52.212-5) — standard commercial terms are incorporated by reference
- Point of contact listed: Hyun Townsley (email: hyun.j.townsley.civ@health.mil) and a telephone number in the extraction
- No technical requirements, deliverable schedule, place of performance, set-aside percentage, NAICS, or clearance requirements are visible in the provided extraction
Technical details
Entry: sync
Review status: Up to date
Logical upstream opportunity: 46378
Notice lineage:
- f684d98884514fceb97a6bcf895eb707 (posted 2026-04-21) - current
Last synced: 2026-04-21T17:47:48.604151+00:00
Last analyzed: 2026-04-21T17:48:59.615798+00:00
Latest package fingerprint: f76d6dd1d78642647db24ae3cd971abf9fcf2a26f3a545ce6aff962d653e96ad
Latest package notice: f684d98884514fceb97a6bcf895eb707
Latest package documents: 1
Recent package history- 2026-04-21T17:47:48.605915+00:00: f684d98884514fceb97a6bcf895eb707 with 1 docs
Labels
Human notes
No human notes yet.